NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: SBC Medical Group's Strategic Investment in OrangeTwist and U.S. Expansion
TL;DR
SBC Medical Group gains a strategic foothold in the lucrative U.S. medical aesthetics market by investing in OrangeTwist, leveraging its network for accelerated growth and market leadership.
SBC Medical Group's investment initiates a multi-phase expansion plan, starting with joint operations and management synergies with OrangeTwist to scale in the U.S. and Southeast Asia.
This partnership aims to bring high-quality, non-invasive aesthetic care to more communities globally, enhancing access to treatments with minimal risk and downtime.
A Japanese medical group with 258 clinics worldwide is now partnering with a U.S. medspa chain, targeting a market projected to grow to $48 billion by 2030.
Found this article helpful?
Share it with your network and spread the knowledge!
SBC Medical Group Holdings Inc., a Japanese company, has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking SBC's official entry into the U.S. market.
The key companies are SBC Medical Group Holdings Inc. (NASDAQ: SBC), a Japanese owner and operator of aesthetic medical clinics, and OrangeTwist, a U.S.-based medspa chain specializing in non-invasive aesthetic treatments.
The U.S. medical aesthetics industry is forecast to grow from $34 billion to $48 billion by 2030, driven by demand for non-surgical treatments like injectables and laser treatments, as well as an aging population seeking aesthetic treatments.
The companies will pursue joint operations, leveraging synergies in the U.S. and Asia, including selling each other's services and products in the U.S. and Japan, and collaborating on new beauty products and services.
OrangeTwist operates 24 locations across six U.S. states and specializes in non-invasive aesthetic treatments, offering injectable, energy-based, and regenerative treatments with an advanced management system for operational consistency.
SBC Medical Group has a network of 258 affiliated clinics worldwide and manages more than six million patient visits annually, with a strong position in Japan and recent expansion in Southeast Asia through a partnership with BLEZ ASIA Co. Ltd.
During 2026, SBC plans to make more strategic investments and partnerships to expand in the U.S. and Southeast Asia, as part of a multiyear roadmap to establish a leading position in the medical aesthetics and wellness market.
Yoshiyuki Aikawa, CEO of SBC, said they look forward to combining OrangeTwist's strengths with SBC's expertise and global network. Robert Settembro, CEO of OrangeTwist, said this allows them to bring exceptional aesthetic experiences to more communities while leveraging SBC's global expertise.
The investment was completed on January 15, 2026, as announced in the press release from Detroit, Michigan.
Curated from NewMediaWire
